$KLAC

Lorig Brian sold $12.4M of KLAC

Lorig Brian (EVP, KLA Global Services) sold 59,586 shares of KLA CORP (KLAC) at $208.13 ($12.40M total) on 2026-08-13 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Lorig Brian
Published Aug 14, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 9:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$KLAC
Neutral
medium confidence
Mentioned
$KLAC
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KLACNeutralLow
01

Why it matters

The newest fact is the disclosed sale size, price, and post-transaction holdings of an EVP under a 10b5-1 plan.

02

Market read

Traders may briefly reassess sentiment around KLAC, but the filing does not introduce new operational, financial, or regulatory information.

03

What to watch

The transaction is explicitly tied to a pre-arranged 10b5-1 plan, which often means the timing is not information-driven.

Relevance 6/10Novelty 4/10Timing: Filed after-hours on 2026-08-14, covering a sale dated 2026-08-13.

Background

The article is a SEC Form 4 insider transaction disclosure for KLA Corp (KLAC).

Company-level read

Ticker impact

$KLACNeutralMedium confidence
Context

KLA insider Form 4 shows EVP Lorig Brian sold 59,586 shares on 2026-08-13 at $208.13, totaling about $12.40M.

Expected impact

Likely limited near-term impact; any effect is more about sentiment than new company fundamentals.

Evidence & confidence

The filing is a routine insider transaction with stated 10b5-1 pre-arrangement, which typically reduces interpretive weight versus unscheduled sales.

Market effects

Minimal, as this is company-specific insider selling without sector-wide signal.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, a large sale can still be read by some traders as management de-risking ahead of uncertainty.

Key entities

  • KLA Corp

    Subject of the Form 4 insider transaction disclosure.

  • Lorig Brian

    EVP, KLA Global Services, reported an open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMATMed

Applied Materials is Down 6% Premarket. Will It Drag Down Lam Research, KLA, and Other Semi Equipment Stocks?

Applied Materials (AMAT) fell about 5.7% premarket after record fiscal Q3 results but guidance for Q4 revenue and margins missed elevated expectations. The company reported record Q3 revenue of $9.1B and non-GAAP EPS of $3.50, and guided Q4 revenue to $10.25B plus or minus $500M and EPS to $4.02 plus or minus $0.20. Lam Research (LRCX) and KLA (KLAC) were little changed premarket.

$AMATMed

Bernstein raises WFE growth estimates, boosts price targets

Bernstein raised its wafer fabrication equipment (WFE) spending forecasts, citing confidence the semiconductor upcycle will continue. It lifted 2026 WFE to $148B (+26.3% YoY), 2027 to $204B (+32.6%), and 2028 to $259B (+27%). Price targets were increased for Lam Research, KLA, and Applied Materials, plus preferences for Tokyo Electron, Kokusai, and ASML.

$PLTRMedAI 8/10

Dow and S&P 500 Hit Record Highs as Palantir Soars 20%, Caterpillar Jumps 10% on Earnings Beat; Oil Plunges 5% on US

US stocks extended gains to three sessions, with the Dow and S&P 500 hitting record highs. Palantir (PLTR) rose about 20% after Q2 results: revenue $1.94B (+93% YoY) and adjusted EPS $0.41 vs $0.35; full-year 2026 revenue outlook raised to $8.150B-$8.158B. Caterpillar (CAT) jumped about 10.5% on Q2 beat and $20.54B revenue. Oil fell ~5% on US-Iran deal hopes.

$MSFTMed

Stocks Tumble as Chipmakers Plunge, Oil Spikes

US MBA mortgage applications fell -6.4% in the week ended July 24, with the purchase mortgage sub-index down -3.6% and the refinancing mortgage sub-index down -9.9%. The average 30-year fixed rate mortgage rose +7 bp to an 11.5-month high of 6.76% from 6.69% the prior week. The outlook for strong Q2 earnings, which continue this week, is a bullish factor for stocks.